Skip to main content

Microbiome Labs launches EpicDefense on Amazon

By: Newsfile
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

A science-first challenge to traditional immune support, now available directly for consumers

Franklinton, North Carolina--(Newsfile Corp. - May 18, 2026) - Microbiome Labs™, a leader in microbiome-based solutions, announces the official launch of EpicDefense™ on Amazon, expanding consumer access to its latest microbiome-focused immune-support formula.

EpicDefense is formulated to support the body's natural defenses and promote respiratory comfort through a direct, science-first approach*. With this launch, Microbiome Labs is delivering a professional-grade immunobiotic formula that shifts the focus from reactive supplementation to proactive, gut-powered resilience.

The formula combines clinically studied strains selected to support respiratory health and immune balance, including:

  • LGG (Lacticaseibacillus rhamnosus GG): Clinically shown to support upper respiratory health and maintain immune balance.
  • BB-12 (Bifidobacterium animalis subsp. lactis): Documented to support natural antibody response to immune challenges.
  • EpiCor®: A whole-food yeast fermentate that supports healthy nasal airflow and respiratory comfort.
  • Zinc Bisglycinate (Albion® Minerals): A chelated form of zinc optimized for absorption to enhance Natural Killer cell functionality.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/11973/297372_microbiome1_550.jpg

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11973/297372_microbiome1.jpg

"For too long, immune support has focused on short-term reactions rather than building resilient systems," says Alicia Galvin, MEd, RD, LD, IFNCP, head of scientific affairs at Microbiome Labs. "EpicDefense reflects a shift toward proactive, gut-powered defense grounded in clinical science and made accessible without compromising rigor. This launch represents our commitment to translating validated microbiome research into real-world solutions."

EpicDefense is non-GMO, soy-free and dairy-free, meeting the rigorous standards healthcare practitioners and microbiome experts expect. To learn more about the company's mission to pioneer health, visit microbiomelabs.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

###

About Microbiome Labs
Microbiome Labs, part of Novonesis Human Health Biosolutions, provides innovative, research-based solutions that support the body's microbial ecosystem. With a focus on clinical application and practitioner partnerships, Microbiome Labs delivers evidence-informed products designed to support overall wellness. Learn more at microbiomelabs.com.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297372

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  263.36
+4.02 (1.55%)
AAPL  299.90
+0.93 (0.31%)
AMD  441.79
+27.74 (6.70%)
BAC  51.27
+0.57 (1.13%)
GOOG  381.99
-2.91 (-0.76%)
META  604.00
+1.39 (0.23%)
MSFT  418.46
+1.04 (0.25%)
NVDA  224.02
+3.41 (1.55%)
ORCL  184.07
+2.61 (1.44%)
TSLA  411.62
+7.51 (1.86%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.